Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

SCS Brandao, JOX Ramos, LT Dompieri… - Cytokine & Growth …, 2021 - Elsevier
The severe form of COVID-19 is marked by an abnormal and exacerbated immunological
host response favoring to a poor outcome in a significant number of patients, especially …

Toll-like receptors and COVID-19: a two-faced story with an exciting ending

L Onofrio, M Caraglia, G Facchini, V Margherita… - Future science …, 2020 - Taylor & Francis
Coronavirus disease 19 (COVID-19) is caused by a novel single-stranded RNA beta-
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1] …

COVID‐19 and toll‐like receptor 4 (TLR4): SARS‐CoV‐2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation

MM Aboudounya, RJ Heads - Mediators of inflammation, 2021 - Wiley Online Library
Causes of mortality from COVID‐19 include respiratory failure, heart failure, and
sepsis/multiorgan failure. TLR4 is an innate immune receptor on the cell surface that …

[HTML][HTML] Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients

MCS Menezes, ADM Veiga, T Martins de Lima… - Scientific reports, 2021 - nature.com
The role of innate immunity in COVID-19 is not completely understood. Therefore, this study
explored the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) …

Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19

M Manik, RK Singh - Journal of medical virology, 2022 - Wiley Online Library
Balanced immune regulation is crucial for recognizing an invading pathogen, its killing, and
elimination. Toll‐like receptors (TLRs) are the key regulators of the innate immune system. It …

[HTML][HTML] Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome?

ASS Girija, EM Shankar, M Larsson - Frontiers in immunology, 2020 - frontiersin.org
The exaggerated immune response induced in the lower respiratory tract against
coronaviruses (CoVs), including CoViD-19 (2019-nCoV), appears to contribute to the …

[HTML][HTML] Toll-like receptor signaling in severe acute respiratory syndrome coronavirus 2-induced innate immune responses and the potential application value of toll …

J Dai, Y Wang, H Wang, Z Gao, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Toll-like receptors (TLRs) are key sensors that recognize the pathogen-associated
molecular patterns (PAMPs) of severe acute respiratory syndrome coronavirus 2 (SARS …

Role of Toll‐like receptors in the pathogenesis of COVID‐19

S Khanmohammadi, N Rezaei - Journal of medical virology, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a pandemic since March 2020. The …

[HTML][HTML] Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic …

SR Dyavar, R Singh, R Emani, GP Pawar… - Biomedicine & …, 2021 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) is the causative
agent of Corona Virus Disease 2019 (COVID-19). Lower production of type I and III …

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

D Darif, I Hammi, A Kihel, IEI Saik, F Guessous… - Microbial …, 2021 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) infection, has emerged in China in December 2019 …